CEBPZ and acute myeloid leukemia: A longer relapse-free interval after first CR, presence of a CBF-AML at diagnosis, lower age at relapse and no previous stem-cell transplantation during first-line therapy are factors associated with more favorable prognosis in this setting but concern a minority of patients [18].